Investor Relations

Financial calendar

 

Subscribe to calendar

Latest press releases

ExpreS2ion Biotechnologies: ExpreS2ion announces the start of the exercise period for warrants of series TO 10

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA, RUSSIA, SOUTH KOREA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER…

Read more

ExpreS2ion to present in upcoming investor and scientific events

Hørsholm, Denmark, 18 November 2024 – ExpreS2ion Biotech Holding AB’s subsidiary ExpreS2ion Biotechnologies ApS (“ExpreS2ion") will participate in upcoming investor and scientific events, including the BioStock Life Science Summit, the Immunotherapies and Innovations for Infectious Diseases Congress and Aktiespararna’s Stora Aktiedagen.

Read more

ExpreS2ion announces TO 10 warrant exercise price and start of exercise period

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA, RUSSIA, SOUTH KOREA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER…

Read more

Latest presentations

Presentation of
Q3 2024

14 November 2024

BioStock Life Science
- From Seed To Success

16 September 2024

Presentation of
half-year results

15 August 2024